One of the biggest pharmaceuticals distributors in Romania,
Relad, has legal problems caused by a second company, Relad
Internațional Pharma, which filed for insolvency last week.
Therefore, after the insolvency filing of Relad Internațional (206
million-euro business in 2009), in response to the tensions in its
commercial relations with major pharmaceutical producers, Relad
Internațional Pharma (170 million-euro business in 2009) filed for
insolvency, as well.
In the latter case, the Bucharest Court of Law ruled for the
starting of simplified insolvency procedures, and appointed Edge
Business Restructuring Advisors based in Bucharest as liquidator,
according to the information available on the Court’s
website.
Relad officials declined comment on this when asked by ZF, saying
they would make a statement only when they had something to
say.
Arin Stănescu, chairman of the Insolvency Practitioners Union,
explained to ZF that simplified insolvency procedure for a company
means bankruptcy procedure, which leaves no other option than
winding-up, according to the legislation in force.
In Relad Internațional’s case, a company with 874.6 million RON
(206 million-euro turnover), both the management and several
creditors petitioned for insolvency, with a court ruling expected
soon, after a number of delays. Relad Internațional Pharma posted
168 million euros in turnover last year, while losses stood at 8.2
million euros and the number of employees reached 240 people.
ZF English
Two Relad companies totalling 350m-euro turnover together file for insolvency
One of the biggest pharmaceuticals distributors in Romania, Relad, has legal problems caused by a second company, Relad Internațional Pharma, which filed for insolvency last week.